Introduction

Registration is now closed.

The EACR conference on Cancer Genomics was widely recognised as the premier European conference dedicated to cancer genomics. In 2024, we are renaming the conference and evolving its content to cover the latest exciting developments: machine learning and artificial intelligence, single cell and spatial analysis of cancers, cell plasticity, cancer immune genomics, data integration and convergence, epigenetics, and genomic instability.

Featuring an exceptional international faculty and extensive networking opportunities, this conference will provide both the possibility and intimate setting for top quality scientific interaction.

We have also partnered with our affiliated journal, Molecular Oncology, to create a 'Call for content' dedicated to this conference: please visit the Abstracts page to find out more.

We look forward to welcoming you to Bergamo for this exciting meeting!

Target audience

Cancer Genomics, Multiomics and Computational Biology 2024 will be relevant to participants from across a number of fields including systems biology, bioinformatics, artificial intelligence and machine learning, cancer medicine, translational research, epigenomics, cancer immunology and molecular pathology. Importantly, early career researchers will have the opportunity to present their work to the international community.

Topics to be covered: 

• Machine learning and artificial intelligence to analyse and integrate multiomic data
• Genomes and transcriptomes of cancers at single cell resolution
• Cell tracking to monitor evolution and plasticity
• Cancer evolution and immune evasion
• Interpreting the cancer genome
• Cancer epigenetics
• Identification of (neo)antigenic landscape and specific antitumor T-cell response in human cancers
• Spatial and 3D analysis of tumors at molecularly annotated single cell resolution

Scientific Programme Committee:

• James Brenton, Cancer Research UK Cambridge Institute, Cambridge, UK
• Carlos Caldas, Cancer Research UK Cambridge Institute, Cambridge, UK
• Nuria Lopez-Bigas, Institute for Research in Biomedicine, Barcelona, Spain
• Elaine Mardis, Institute for Genomic Medicine Columbus, USA
• Yardena Samuels, Weizmann Institute of Science, Rehovot, Israel

Follow us on X for updates @EACRnews 

Above: the beautiful city of Bergamo